🇵🇹 Daily Portugal news for expats & investors — FREE Subscribe

Optimize Buys Martifer Shares at €2.25 to Sabotage Visabeira's €2.057 OPA Before the 3 June Acceptance Window Closes

Optimize Investment Partners is buying Martifer shares at €2.25 to push the market price above Visabeira's €2.057 OPA offer and starve the bid of acceptances before the 3 June window closes. The fund holds roughly 4% and is publicly contesting the contrapartida.

Optimize Buys Martifer Shares at €2.25 to Sabotage Visabeira's €2.057 OPA Before the 3 June Acceptance Window Closes

Optimize Investment Partners is running an open-market campaign to derail the Visabeira Indústria takeover bid for Martifer, paying €2.25 per share to lift the on-screen tape above the €2.057 contrapartida Visabeira tabled with the CMVM. The fund's strategy — confirmed in Tuesday-night and Wednesday-morning filings — is to make the OPA acceptance economically unattractive ahead of the 3 June 2026 close of the formal window, while reinforcing a blocking position on the Vila Nova de Famalicão construction-and-metalworks group's register.

The Mechanics of the Squeeze

Optimize is buying Martifer in lots of up to four million shares at €2.25, a roughly 9.4% premium to the Visabeira contrapartida — and crucially above the €2.057 floor that has been the OPA reference since the offer was lodged. The CMVM-supervised window opened on 18 May 2026 and runs through 3 June; if Visabeira fails to clear the threshold for squeeze-out or delisting (around 90% of the share capital and voting rights), the OPA either lapses or settles short of its core objective of delisting Martifer from Euronext Lisbon. To delist, the bidder needs roughly 14 million shares to be tendered into the offer.

The Bidder Block

The OPA is structured as a hard core arrangement: Visabeira Indústria and Mota-Engil are each set to hold 37.5% of Martifer after the OPA closes, with the founding Martins brothers retaining 25%. That trio is the operational thesis Carlos Saraiva (Visabeira) tabled when the offer was launched — a refocus of Martifer's wind, structural-steel and naval business on the Mota-Engil construction pipeline plus the Visabeira industrial portfolio. The Martifer board signed off on the €2.057 price in a fairness-opinion process before the CMVM filing.

Optimize's Argument

The Optimize position — a ~4% stake on the most recent CMVM disclosure file — argues the €2.057 reading does not capture Martifer's residual value: a 2025 revenue line at multi-year highs, an order book that has refilled on the back of the Sines-rail-Minho infrastructure pipeline, and an exposure to the metalworks side of the European defence and renewables capex cycle. The fund's framing letter to minority shareholders explicitly invites them to refuse the OPA and sell into Optimize's bid at €2.25, which simultaneously rewards the seller and increases the share Optimize controls. The minority-shareholder association ATM has been broadly aligned, contesting the price as insufficient.

The Tape Effect

The on-screen Martifer line on Euronext Lisbon has been trading at or above €2.25 for most of the past five sessions — a price that has held only because of the Optimize buy-side. Without the fund's bid, the natural tape would clear at or below the OPA reference. The implied market signal is that, absent Optimize, retail shareholders would tender — but with the higher market quote sitting above the contrapartida for the closing fortnight of the window, the rational economic move is to sell on-screen to Optimize rather than tender to Visabeira at the lower price. A failed OPA leaves Visabeira with whatever has been tendered (likely above 50% but below the delist threshold) and a re-evaluation cycle on a second offer or a long-tail co-existence with a meaningful minority bloc.

What This Means for Expats — The Bottom Line

  • The Visabeira OPA is the first contested industrial takeover of the 2026 PSI cycle. Most Portuguese OPAs settle on the original contrapartida; the Martifer file is the rare case where an activist fund is openly running an interventionist counter-strategy on the open tape rather than negotiating off-market with the bidder.
  • Optimize is staking the fund's track record on this trade. Buying above the OPA reference is only profitable if the squeeze succeeds and Martifer either remains listed at a fundamentally re-rated price or re-attracts a higher second offer. The downside scenario is a successful Visabeira delisting at €2.057 — in which case Optimize is locked into illiquid Martifer paper at a 9% premium.
  • The CMVM file is open through 3 June; the closing rate will be the headline. If Visabeira clears the delisting threshold, the deal settles and the Mota-Engil-Visabeira-Martins block runs the asset privately. If Visabeira falls short, the OPA either lapses or the bidder revises terms — and Optimize gets a positive mark-to-market on the residual public float.
  • Mota-Engil is the silent winner either way. The Linhares de Andrade group picks up a 37.5% block of Martifer at €2.057 in the success scenario, or retains its pre-OPA exposure with no incremental capital deployed in the failure scenario. The biomethane, infrastructure and Minho-rail order-book story we've covered separately keeps the parent's pipeline intact regardless.

The CMVM publishes daily acceptance rates over the window's closing fortnight; Visabeira files the final tally within five business days of the 3 June close.